Hospital Clínic de Barcelona, officially Hospital Clínic i Provincial de Barcelona, is a university hospital founded in 1906 and based in Barcelona. It opened its doors on December 23, 1906, with a capacity of 400 patients, some of which were moved from Hospital de la Santa Creu.

There are 819 beds in Hospital Clínic, University of Barcelona.

During the past decade, Hospital Clínic, University of Barcelona conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Clínic, University of Barcelona" #1 sponsor was "LEO Pharma" with 2 trials, followed by "BioVentrix" with 1 trials sponsored, "InnaVirVax" with 1 trials sponsored, "InspireMD" with 1 trials sponsored and "Loma Linda University" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Clínic, University of Barcelona" #1 collaborator was "Medtronic" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "California Walnut Commission" with 1 trials as a collaborator and "Ohio State University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Clínic, University of Barcelona" are "HIV" (2 trials), "Liver Neoplasms" (2 trials), "AIDS" (1 trials), "Acidosis, Lactic" (1 trials) and "Age Related Cognitive Decline" (1 trials). Many other conditions were trialed in "Hospital Clínic, University of Barcelona" in a lesser frequency.

Most popular intervention types in "Hospital Clínic, University of Barcelona" are "Device" (2 trials), "Drug" (2 trials), "Biological" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Seocalcitol" (2 trials), "(BMS/DES)" (1 trials), "Electrical isolation of pulmonary veins" (1 trials), "Electrical isolation of the pulmonary veins" (1 trials) and "MGuard Prime" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Clínic, University of Barcelona" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Clínic, University of Barcelona". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Hospital Clínic, University of Barcelona, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Clínic, University of Barcelona, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".